United States · FDA National Drug Code directory
Carbatrol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54092-172_4186c118-9875-4b12-b652-3fbfaf4e6622
- Product NDC
- 54092-172
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- carbamazepine
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19970930
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBAMAZEPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-172-12) · 54092-172-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →